Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients

References

• Guaraldi G, Orlando G, Zona S, et al. 2011. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 53:1120–1126.
   PubMed Web of Science ®Google Scholar
• Freiberg MS, Chang CC, Kuller LH, et al. 2013. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 173:614–622.
   PubMed Web of Science ®Google Scholar
• Lohse N, Gerstoft J, Kronborg G, et al. 2011. Comorbidity acquired before HIV diagnosis and mortality in persons infected and uninfected with HIV: a Danish population-based cohort study. J Acquir Immune Defic Syndr. 57:334–339.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Phillips AN. 2009. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 338:a3172.
   PubMed Web of Science ®Google Scholar
• Longenecker CT, Sullivan C, Baker JV. 2016. Immune activation and cardiovascular disease in chronic HIV infection. Curr Opin HIV AIDS. 11:216–225.
   PubMed Web of Science ®Google Scholar
• Mussini C, Lorenzini P, Cozzi-Lepri A, et al. 2015. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV. 2:e98–106.
   PubMed Web of Science ®Google Scholar
• Leung V, Gillis J, Raboud J, et al. 2013. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One. 8:e77665.
   PubMed Web of Science ®Google Scholar
• Castilho JL, Shepherd BE, Koethe J, et al. 2016. CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy. AIDS. 30:899–908.
   PubMed Web of Science ®Google Scholar
• Lapadula G, Cozzi-Lepri A, Marchetti G, et al. 2013. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. AIDS. 27:769–779.
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S, Deeks SG. 2015. CD4/CD8 ratio: an emerging biomarker for HIV. Lancet HIV. 2:e76–e77.
   PubMed Web of Science ®Google Scholar
• Robbins GK, Spritzler JG, Chan ES, et al. 2009. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect DIS. 48:350–361.
   PubMed Web of Science ®Google Scholar
• Kaufmann GR, Furrer H, Ledergerber B, et al. 2005. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis. 41:361–372.
   PubMed Web of Science ®Google Scholar
• Neuhaus J, Angus B, Kowalska JD, et al. 2010. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 24:697–706.
   PubMed Web of Science ®Google Scholar
• Manner IW, Troseid M, Oektedalen O, et al. 2013. Low Nadir CD4 Cell Count Predicts Sustained Hypertension in HIV-Infected Individuals. J Clin Hypertens (Greenwich). 15:101–106.
   PubMed Web of Science ®Google Scholar
• De Socio GV, Ricci E, Maggi P, et al. 2014. Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. Am J Hypertens. 27:222–228.
   PubMed Web of Science ®Google Scholar
• Baekken M, Os I, Stenehjem A, et al. 2009. Association between HIV infection and attenuated diurnal blood pressure rhythm in untreated hypertensive individuals. HIV Med. 10:44–52.
   PubMed Web of Science ®Google Scholar
• Kent ST, Bromfield SG, Burkholder GA, et al. 2016. Ambulatory blood pressure monitoring in individuals with HIV: a systematic review and meta-analysis. PLoS One. 11:e0148920
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 20:2183–2189.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, et al. 2013. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level–the “normotensive non-dipper” paradox. Chronobiol Int. 30:87–98.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Thijs L, Staessen JA, et al. 2009. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens. 23:645–653.
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, et al. 2016. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Sala C, Tadic M, et al. 2015. Non-dipping pattern and subclinical cardiac damage in untreated hypertension: a systematic review and meta-analysis of echocardiographic studies. AJHYPE Hypertens. 28:1392–1402.
   PubMed Web of Science ®Google Scholar
• Cerrato E, D'Ascenzo F, Biondi-Zoccai G, et al. 2013. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J. 34:1432–1436.
   PubMed Web of Science ®Google Scholar
• Thiara DK, Liu CY, Raman F, et al. 2015. Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults. J Infect Dis. 212:1544–1551.
   PubMed Web of Science ®Google Scholar
• Fontes-Carvalho R, Mancio J, Marcos A, et al. 2015. HIV patients have impaired diastolic function that is not aggravated by anti-retroviral treatment. Cardiovasc Drugs Ther. 29:31–39.
   PubMed Web of Science ®Google Scholar
• Mansoor A, Golub ET, Dehovitz J, et al. 2009. The association of HIV infection with left ventricular mass/hypertrophy. AIDS Res Hum Retroviruses. 25:475–481.
   PubMed Web of Science ®Google Scholar
• Baekken M, Os I, Sandvik L, et al. 2008. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens. 26:2126–2133.
   PubMed Web of Science ®Google Scholar
• Manner IW, Baekken M, Oektedalen O, et al. 2012. Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study. Blood Press. 21:311–319.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. 2009. A new equation to estimate glomerular filtration rate. Ann Intern Med. 150:604–612.
   PubMed Web of Science ®Google Scholar
• Okada K, Mikami T, Kaga S, et al. 2011. Early diastolic mitral annular velocity at the interventricular septal annulus correctly reflects left ventricular longitudinal myocardial relaxation. Eur J Echocardiogr. 12:917–923.
   PubMed Web of Science ®Google Scholar
• Schwartz T, Sanner H, Gjesdal O, et al. 2014. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann Rheum Dis. 73:1805–1810.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. 2005. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 18:1440–1463.
   PubMed Web of Science ®Google Scholar
• Schillaci G, Maggi P, Madeddu G, et al. 2013. Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study. J Hypertens. 31:560–567. Discussion 7.
   PubMed Web of Science ®Google Scholar
• Borkum M, Wearne N, Alfred A, et al. 2014. Ambulatory blood pressure profiles in a subset of HIV-positive patients pre and post antiretroviral therapy. CVJA. 25:153–157.
   Web of Science ®Google Scholar
• De Socio GV, Bonfanti P, Martinelli C, et al. 2010. Negative influence of HIV infection on day-night blood pressure variability. J Acquir Immune Defic Syndr. 55:356–360.
   PubMed Web of Science ®Google Scholar
• Lederman MM, Calabrese L, Funderburg NT, et al. 2011. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis. 204:1217–1226.
   PubMed Web of Science ®Google Scholar
• Neuhaus J, Jacobs DR Jr, Baker JV, et al. 2010. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 201:1788–1795.
   PubMed Web of Science ®Google Scholar
• Helleberg M, Kronborg G, Ullum H, et al. 2015. Course and clinical significance of CD8+ T-cell counts in a large cohort of HIV-infected individuals. J Infect Dis. 211:1726–1734.
   PubMed Web of Science ®Google Scholar
• Cao W, Mehraj V, Kaufmann DE, et al. 2016. Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era. J Int AIDS Soc. 19:20697
   PubMed Web of Science ®Google Scholar
• Cao W, Mehraj V, Trottier B, et al. 2016. Early initiation rather than prolonged duration of antiretroviral therapy in hiv infection contributes to the normalization of CD8 T-Cell Counts. Clin Infect Dis. 62:250–257.
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S, Sainz T, Lee SA, et al. 2014. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 10:e1004078.
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S, Perez-Elias MJ, Dronda F, et al. 2014. Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio. PLoS One. 9:e85798.
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S, Gutierrez C, Vallejo A, et al. 2013. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect. 66:57–66.
   PubMed Web of Science ®Google Scholar
• Appay V, Sauce D. 2008. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol. 214:231–241.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Syrseloudis D, Dimitriadis K, et al. 2008. Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension. J Hum Hypertens. 22:501–508.
   PubMed Web of Science ®Google Scholar
• von Kanel R, Jain S, Mills PJ, et al. 2004. Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens. 22:2087–2093.
   PubMed Web of Science ®Google Scholar
• Erdogan D, Icli A, Aksoy F, et al. 2013. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure. Chronobiol Int. 30:973–980.
   PubMed Web of Science ®Google Scholar
• Duprez DA, Neuhaus J, Kuller LH, et al. 2012. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One. 7:e44454.
   PubMed Web of Science ®Google Scholar
• Seaberg EC, Benning L, Sharrett AR, et al. 2010. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke. 41:2163–2170.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Nakagawa K, Kimura M, et al. 2002. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol. 40:2039–2043.
   PubMed Web of Science ®Google Scholar
• Maio R, Perticone M, Sciacqua A, et al. 2012. Oxidative stress impairs endothelial function in nondipper hypertensive patients. Cardiovasc Ther. 30:85–92.
   PubMed Web of Science ®Google Scholar
• Jerrard-Dunne P, Mahmud A, Feely J. 2007. Circadian blood pressure variation: relationship between dipper status and measures of arterial stiffness. J Hypertens. 25:1233–1239.
   PubMed Web of Science ®Google Scholar
• Manner I, Baekken M, Kvale D, et al. 2013. Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med. 14:354–361.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Bieniaszewski L, O’Brien E, The “Ad Hoc’ Working Group, et al. 1997. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertension. 29:30–39.
   PubMed Web of Science ®Google Scholar
• Remick J, Georgiopoulou V, Marti C, et al. 2014. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation. 129:1781–1789.
   PubMed Web of Science ®Google Scholar
• Hsue PY, Hunt PW, Ho JE, et al. 2010. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 3:132–139.
   PubMed Web of Science ®Google Scholar
• Holloway CJ, Ntusi N, Suttie J, et al. 2013. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 128:814–822.
   PubMed Web of Science ®Google Scholar
• Nayak G, Ferguson M, Tribble DR, et al. 2009. Cardiac diastolic dysfunction is prevalent in HIV-infected patients. AIDS Patient Care STDS. 23:231–238.
   PubMed Web of Science ®Google Scholar
• Mondy KE, Gottdiener J, Overton ET, et al. 2011. High prevalence of echocardiographic abnormalities among hiv-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis. 52:378–386.
   PubMed Web of Science ®Google Scholar
• Frerichs FC, Dingemans KP, Brinkman K. 2002. Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors. N Engl J Med. 347:1895–1896.
   PubMed Web of Science ®Google Scholar
• Parati G, Stergiou G, O’Brien E, et al. 2014. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 32:1359–1366.
   PubMed Web of Science ®Google Scholar